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Abstract
Background Taking regular medication has been shown to have an impact on the daily lives of patients and their families. 
Objective To explore the medication-related experiences of patients and their families when a child or young person is pre-
scribed regular medication. Setting A specialist U.K. paediatric hospital. Method Semi-structured face-to-face interviews 
of 24 parents/carers, children or young people, who had been taking two or more medications for 6 weeks or longer. The 
themes explored included the medication regimen, formulation, supplies, social aspects and adverse effects. The data was 
analysed using NVIVO version 11. Main outcome measure The experiences of patients, and their parents/carers, when a child/
young person takes regular medication. Results Participants described a range of experiences associated with taking regular 
medication. Medication-related challenges were experienced around the timing of administration which was managed over 
24 h rather than waking hours. Updating medication doses for administration at school was often delayed. Unintended non-
adherence was cited as the biggest challenge with a range of strategies employed to manage this. The internet was commonly 
used as a source of additional information accessed for reassurance and adverse effects but there were varying experiences 
of using patient forums/help groups. Other challenges included the adequacy of information, travelling with medication, 
formulation issues, arranging supplies and adverse effects. Conclusion Patients and parents experience many challenges with 
children’s medication. Individualised treatment options should be considered. Further research is required to determine how 
these experiences may be managed including the role of paediatric medication review.
Keywords Drug therapy · Medication therapy management · Paediatrics · Qualitative research · Self management · United 
Kingdom
Impacts on practice
• Patients and their parents experience a range a medica-
tion-related challenges when a child takes regular medi-
cation.
• Pharmacists and other healthcare professionals, by being 
aware of these challenges, have the opportunity to further 
optimise medication use in this population.
Introduction
Efforts to assist patients with adherence might improve the 
benefits of prescribed medication [1]. In children, adher-
ence may be influenced by parents’/carers’ beliefs about the 
condition, regimen, child resistance, daily life and health 
professional influence [2].
Taking medication has been shown to place a burden on 
patients’ daily lives including the routine of taking medica-
tion, monitoring and travelling [3, 4]. The formulation, quan-
tity, packaging, brand, adverse effects and negotiating the 
healthcare system add to this burden [3]. The stigma from 
family and friends associated with taking medication may 
add a psychological burden and influence patients’ beliefs 
about medication [3].
The experiences of children, and families, taking medi-
cation have been described for asthma [5, 6], diabetes [6], 
cystic fibrosis [7, 8], attention deficit hyperactivity disorder 
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[9], inflammatory bowel disease [10], diabetes [11] and 
post-transplant patients [12, 13]. Challenges were described 
around medication use in school, taking in front of peers, 
social activities, regimen rigidity, reliance on family and 
adherence. The desire to achieve normality in adolescents 
can lead to patient-initiated changes to their medication [14].
Treatment burden can lead to poor adherence, waste and 
poor outcomes [15]. Minimally disruptive medication tai-
lored to the realities of patients’ daily lives could greatly 
improve quality of life [15]. For children and young people, 
understanding how medication taking affects daily life may 
help identify opportunities for optimising use.
Aim of the study
To explore the treatment-related experiences when children 
and young people take regular prescribed medication.
Ethics approval
Approved by the West of Scotland Research Ethics Commit-
tee 16/3/17, reference 17/WS/0038.
Method
This study was undertaken at Birmingham Children’s Hos-
pital -a UK paediatric hospital.
Purposive sampling by ward pharmacists of in-patients 
aged up to 18 years who had been taking two or more pre-
scribed medications concurrently at home, prior to admis-
sion, for 6 weeks or longer. Each participant was provided 
with an information sheet. Participants who wished to join 
the study were identified to JA who took consent. Consent 
was taken from the patient’s parent/carer who acted as the 
study participant if the child was under 16 years old or the 
patient if aged 16 years or older. Children under 16 years 
were encouraged to take part in the study and assent was 
taken based on their understanding.
Twenty-four participants were recruited into the study—
eight from each age group 0–5, 6–10 and 11–18 years to 
provide a breadth of experience across the full childhood age 
range. The study was not offered to non-English speakers 
due to the short time opportunity to arrange an interpreter.
Data collection
Face-to-face semi-structured interviews, with pre-piloted 
questions, were recorded and transcribed verbatim. The 
interviews took place during the patient’s in-patient stay and 
were undertaken by JA, a pharmacist not involved in the care 
of the study patients. The questions covered in the inter-
views were identified through a literature review (Fig. 1). 
Demographic/background information recorded included the 
patient’s age and usual medication.
Data analysis
The interview transcripts were analysed using NVivo ver-
sion 11. Thematic analysis was undertaken by JA using the 
6 phases described by Braun and Clarke [16]. The themes 
identified were independently reviewed by KAW and DRPT.
Results
Twenty-three parents and one 16-year-old patient consented. 
Assent was taken from 5 patients who contributed to the 
interviews with their parents. Two were aged 11 years, two 
14 years and one 15 years.
In total 166 prescribed medications were taken by patients 
at home (Table 1). The number of medications prescribed for 
each patient ranged from 3 to 15 (mean 7, mode 5).
Participants described many experiences of how taking 
medication impacted on their lives. These have been sum-
marised into common themes. Participants identified addi-
tional experiences that were not part of the original inter-
view framework. These included: the rigidity that parents 
demonstrated around dose times, managing dose changes 
in school, the internet as an information resource and for 
liaising with other parents and the influence of medication 
labelling.
The timing of doses
Participants experienced challenges around the timing/fre-
quency of doses. A four-times-daily regimen was the most 
difficult to adhere to due to the time available within daily 
activities. Participants described extending the duration of 
their day, arranging doses around meals/other medication 
and maintaining a precise time gap between doses.
We have to keep the gaps in-between equal, night-time 
especially because she has to have one at midnight, 
one at 2am then she’s due one at 6am. I have to stay 
up late until 2 o’clock and then I sleep after I’ve given 
her medicine. [Father of Patient 20 prescribed oral 
omeprazole, erythromycin, dexamethasone, glycopyr-
ronium and co-trimoxazole.]
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Fig. 1  Interview questions Interview Topic: The Medication Regimen
Question set:
• Tell me about your daily regime of taking/administering medication.
• What changes have you had to make to your daily life to take in to account 
taking medication? 
• What changes have you had to make to the medication regimen to fit it 
around your daily lives? Have you adjusted the schedule yourself?
• What aspects of medication taking are the most challenging? How have 
you solved these challenges?
• Have you sought the advice of a healthcare professional for help with your 
medication taking schedule?
• Do you use any aids to help with remembering to take/administer 
medication?
• How has medication impacted on you/your child’s family life and social life 
for example, holidays and visiting family/friends?
• Have you looked up any further information about the medication yourself? 
Where did you look? What did you wish to find out?
Interview Topic: Medication Formulation and Packaging
Question set: 
• Have you experienced any problems with administering/taking the 
medication? For example, size of the tablet, taste or preparation to get the 
prescribed dose? How have you managed to get around this?
• Is the number of doses difficult to manage? How have you managed to get 
around this?
• Does the packaging that the medication comes in cause you any 
difficulties? How have you got around this?
• Have you experienced any problems if the brand/manufacturer of 
your/your child’s medication changes?
• What written instructions were you provided with about your medication? 
Were they useful? Would you have liked any additional information?
• If the dose changes, when/how do you usually get told about this? Do you 
receive any written information?
Interview Topic: Managing Supplies of Medication
Question set: 
• Have you encountered any difficulties obtaining prescriptions or supplies 
of medication for you/your child?
• On average, how much time do you spend dealing with the healthcare 
system around medication? For example, arranging supplies.
• Have you ever received inadequate or conflicting information about your 
medication?
• Is the way that information is provided to you about medication suitable? 
For example, face-to-face with the prescriber, pharmacist or nurse.
Interview Topic: Adverse Effects 
Question set: 
• Have you/your child experienced any side effects from the medication? 
• How did the side effect affect you/your child?
• Did you know what to do?
• Was it something that you knew could happen?
• Had anyone spoken to you about the side effects?
Interview Topic: Other Experiences
Question set:
• Are there any other challenges around medication that I have not 
mentioned that you would like to raise?
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To make the medication regimen fit around daily life partici-
pants adjusted the timing of medication or daily activities. 
Establishing a routine was identified as important. Few par-
ticipants sought advice about their medication schedule from 
a healthcare professional. Others sought advice on changing 
the timing of medication. This included adjusting the times 
away from the hospital administration times. Two partici-
pants had changed the regimen themselves.
Medication at school
Participants described their experiences of medication at 
school. Whilst some had positive experiences others avoided 
the need to administer at school. Difficulties included edu-
cating teachers, administration in front of peers, transporting 
medication, limitations on frequency of administration and 
arranging additional medication for storage at school. School 
staff were unable to administer updated doses of medication 
following a verbal instruction of a dose change when medi-
cation was labelled with the previous dose.
If she’s gone to an out-patient appointment and her 
doses have changed she’ll have an old packet that 
hasn’t been labelled properly. Then I’m saying to [the 
school] the doses have changed. The school say ‘well 
we can’t give it because the dose that we’ve got is 
incorrect’. Then I’m waiting a week for the prescrip-
tion to come or potentially two weeks for a letter from 
the hospital to get to the GP and then the GP to write 
out a new dose of medication. Quite often I’ll have to 
keep her off school because they can’t give the new 
dose. [Mother of Patient 21 prescribed oral desmopres-
sin, levothyroxine, hydrocortisone and subcutaneous 
somatropin.]
Medication adherence
Many participants cited remembering to give their child’s 
medication as their biggest challenge. Strategies employed 
to reduce the risk of unintended non-adherence included a 
mobile phone alarm, placing medication where it was vis-
ible, home-made chart/administration record and verbal 
reminders. A number of participants had purchased medi-
cation compliance aids. A second checking process had been 
adopted by one participant to reduce the risk of error.
I’ve had to put a list, like a checklist, on my fridge to 
make sure that I know I gave it him as well. I didn’t 
before and I used to feel like I was forgetting so I wrote 
it down so I know I gave it him. [Mother of Patient 14 
prescribed oral multivitamins, vitamin E, ranitidine, 
pancreatin, nebulised sodium chloride, salbutamol and 
colistimethate.]
My husband and I always check them together to make 
it easier. In the past my mum did because she was a 
nurse and she taught me to double check which is bril-
liant because there have been times when I’ve been 
tired… [Mother of Patient 9 prescribed via gastros-
tomy senna,  Movicol®, paracetamol, carbamazepine, 
levetiracetam, omeprazole, buccal midazolam, inhaled 
oxygen, rectal phosphate and sodium citrate.]
Medication information
Participants found the information provided with their medi-
cation useful. Some described their experiences of receiv-
ing information about dose changes in clinic. This was pro-
vided verbally, with insufficient time for participants to write 
down, or with a hand-written note that was difficult to read.
That’s how we had to learn how to increase the dose. 
It was just a little scribble on a piece of paper from the 
consultant at first and the actual letter comes about 
three weeks later. I hope that when it finally comes 
through I’ve read this squiggle correctly and remem-
bered what he said in clinic. [Mother of Patient 24 
prescribed oral sodium valproate, carbamazepine and 
inhaled salbutamol.]
Table 1  Type of prescribed medication
Medication Number 
prescribed
Vitamin and mineral supplementation 18
Antiepileptic 17
Treatment of gastro-oesophageal reflux disease 12
Inhaled bronchodilator 11
Treatment of constipation 11
Prophylactic antibiotics 9
Analgesia 8
Inhaled corticosteroid 6
Oral corticosteroid 6
Antiemetic 5
Nebulised sodium chloride 5
Oral antihistamine 4
Emollient 4
Pancreatin 4
Insulin 3
Nasal corticosteroid 3
Nebulised antibiotic 3
Nebulised DNase 3
Oral bronchodilator 2
Leukotriene antagonist 2
Other medications 30
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Few participants felt that they had received inadequate or 
conflicting information. Others believed that they were not 
told enough about access to medication outside of the hos-
pital, how to use their medication, adverse effects or the type 
of medication prescribed.
We have some people telling us it’s really bad for him 
to be on [steroids]. When he’s older he’s going to suf-
fer with his bones. When we went to the ‘out-of-hours’ 
at [the local hospital] it was one of the doctors there. 
So, we listen to him and then we’re told we need [the 
steroids by the respiratory team] so I’m like what do I 
do? [Mother of Patient 17 prescribed oral theophylline 
and montelukast. Inhaled salbutamol and  Seretide®. 
Intranasal fluticasone.]
Participants commonly researched further information about 
their medication using the internet. This was for general 
interest, assurance, alternative treatment options, how to use 
their medication and information on adverse effects. Other 
participants avoided using the internet through fear of find-
ing out something of concern.
At the end of the day we are responsible for [Patient 
1]. I have researched them, I don’t understand half of 
it, but I’ve got an understanding to maybe ask the right 
questions and just check because we are responsible 
for him and we’ve not had anyone who’s on regular 
medicines in the family. [Mother of Patient 1 pre-
scribed oral  Movicol®, cetirizine, theophylline, hydro-
cortisone. Inhaled salbutamol and  Seretide®. Intranasal 
fluticasone.]
Participants recounted experiences of using on-line support 
groups. Whilst helpful for some they created uncertainty 
for others through reading other patients’ experiences and 
advice from ‘expert parents’. One parent utilised a Facebook 
page for epilepsy and found that the reassurance provided 
reduced the need to contact the medical team.
I’ve joined a parenting group and I thought it would be 
nice to talk to other parents in the same position. They 
were saying things like if you give too much Creon 
then it will do this, you need to provide this sort of 
thing. I ignored it in the end and thought it’s probably 
best not to listen to you. Listen to the professionals. 
[Mother of Patient 14 prescribed oral multivitamins, 
vitamin E, ranitidine and pancreatin, nebulised sodium 
chloride, salbutamol and colistimethate.]
Different heart mum’s groups. They’ll say they were 
on captopril but now they’re on something and I’m 
like, well, what’s that then? Is it like captopril? Why 
is your daughter now taken off captopril and put on 
to this one and I’m thinking can’t [Patient 15] be 
taken off captopril and put on this one? [Mother of 
Patient 15 prescribed oral captopril and inhaled sal-
butamol (previously digoxin).]
I joined a parents’ for epilepsy Facebook. Sometimes 
you just think the doctor only has so much time with 
you and they have so much information that they can 
give you. It can be quite lonely out there when you 
don’t know what you’re doing. Reading about her hair 
falling out and the other mums and dads are saying 
it’s fine…it will grow back it’s not forever, she’s not 
going to end up completely bald. It can be reassur-
ing. [Mother of Patient 24 prescribed oral sodium val-
proate, carbamazepine and inhaled salbutamol.]
Medication formulation and packaging
Child resistance due to taste, colour, tablet size, refusal and 
disliking inhaler devices were cited. The ease of tablets com-
pared with liquid formulations was mentioned.
It takes a lot more time to deal with liquids because 
you have to keep drawing them up. If I’m late for 
school, I can just grab a tablet and quickly take it. But 
when it comes to liquid I had to stay over a bit longer 
and draw it up. It’s more convenient with it being tab-
lets. [Patient 2 prescribed oral phenoxymethylpenicil-
lin, folic acid, paracetamol, ibuprofen and morphine 
sulphate.]
Parents used a variety of methods to aid their child’s medica-
tion taking. These included: distraction, tasting medication 
to empathise with their child, taste masking and changing 
the formulation.
Some participants had experienced difficulties with medi-
cation packaging and expressed concern about waste when 
receiving large bottles. Labelling caused some anxiety. A 
‘cytotoxic’ label caused one participant to decide against 
taking their medication. An ‘unlicensed medication’ label 
on a bottle of phenobarbital caused concern.
I think the other thing was his phenobarbital coming 
with a great big label on saying ‘unlicensed medicine’. 
My mum saw it and she was like ‘oh my gosh! what 
are they doing?’. [Mother of Patient 11 prescribed oral 
phenytoin, vigabatrin, levetiracetam and ranitidine 
(previously phenobarbital).]
Few participants described challenges if the manufacturer 
of their medication changed. Others described uncertainty 
about whether they were receiving the correct medication, 
difficulty remembering the name, intolerance of alternative 
brands and the inconvenience of requiring refrigerated stor-
age depending on the brand dispensed.
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We have to try and keep to the same brand but we’ve 
found a lot of community pharmacists give us a dif-
ferent brand. Now the GP puts it on the prescription. 
Epilim liquid and syrup get interchanged. The syrup 
isn’t good for her teeth, it’s quite sugary and quite thick 
to [administer] to her. We do find one week we’ll get 
liquid and another we’ll get syrup. [Mother of Patient 
24 prescribed oral sodium valproate, carbamazepine 
and inhaled salbutamol.]
Travelling with medication
Administering medication was considered awkward in the 
presence of other people.
We’re in a café and we’re drawing up meds and every-
one’s looking at you thinking ‘what are they doing!’. 
Especially when you’re out and about that’s the worst. 
[Mother of Patient 15 prescribed oral captopril and 
inhaled salbutamol (previously digoxin).]
Transportation was described as a problem for daily travel 
and holidaying. Particular problems were with refrigerated 
medication and large bottles. Some participants had pur-
chased oral syringes with caps to carry doses. One partici-
pant risked the period of time that their refrigerated medica-
tion was transported at room temperature. Other participants 
used medication compliance aids for holidays and described 
using ice blocks to keep medication cool. Some participants 
avoided going on holiday due to the perceived difficulties 
over transporting and accessing medication.
Holidays is a hard one. When we got there we had 
a cold bag with ice packs in it and obviously the ice 
packs were melting and we had to stop and get ice from 
different shops. We had to stop at three different stops 
to get ice to cool his medicines down which was really 
hard. It was so hot the ice was melting and then when 
I got there the labels had come off! [Mother of Patient 
18 prescribed oral sirolimus, mycophenolate, sodium 
bicarbonate, d-mannose and sodium feredetate.]
Managing supplies of medication
Participants who received their medication through the 
hospital described the ease of receiving a prescription in 
an out-patient clinic and their medication from the hospi-
tal pharmacy. Those receiving medication through their GP 
highlighted community pharmacy prescription collection 
services and on-line ordering as useful. However, a num-
ber of participants described some difficulties obtaining 
medication in primary care. These were: the GP declining 
to prescribe, unavailability in community pharmacy, dif-
ficulties with the repeat prescription process and delayed 
communication between hospital and GP. Participants 
described the advanced planning that they undertook to 
maintain medication supplies.
Initially yes, it was a very big problem. Trying to 
get the GP to prescribe something that’s not listed in 
his bog standard BNF was a big issue. He refused to 
prescribe anything so now I literally don’t go to the 
GP. [Mother of Patient 18 prescribed oral sirolimus, 
mycophenolate, sodium bicarbonate, d-mannose and 
sodium feredetate.]
There’s certain meds the GP won’t prescribe. They’re 
like, ‘well, hang on they shouldn’t be on that med 
anyway’. That’s the way they see it. Even the digoxin, 
when we brought the forms to the GP after he got dis-
charged he was looking at it and like ‘Really! Is he 
on that!? Are you sure!?’. [Mother of Patient 15 pre-
scribed oral captopril and inhaled salbutamol (previ-
ously digoxin).]
The time taken to arrange supplies of medication focussed 
around two themes - ordering frequency and the time it took 
for the prescription and supply. In particular, having to fre-
quently arrange supplies of medication due to a lack of syn-
chronisation. This required ordering at least one medication 
weekly.
The phenobarbital in particular. We were told that we 
could order it and obtain it within 48 h. But subse-
quently actually we need 10 days. We’ve never run out 
but there was once in particular it was really challeng-
ing. [Mother of Patient 11 prescribed oral phenytoin, 
vigabatrin, levetiracetam and ranitidine (previously 
phenobarbital).]
Adverse effects
Half of participants had experienced adverse effects rang-
ing from diarrhoea to thrombocytopenia. Most had been 
informed by the healthcare team, other parents or through 
self-research. Most participants sought advice from nurses 
within their specialty. Mild side effects were managed by 
participants.
Discussion
This study has identified many challenges that children, 
young people and their parents experience when a child 
or young person is taking regular prescribed medication. 
Similar experiences to those in the published literature were 
described including adherence, regimen inflexibility, impact 
on social activities, travelling with medication, administra-
tion at school and arranging repeat supplies. In addition, this 
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study has identified how parents interpret dosing instruc-
tions, challenges around implementing dose changes in 
school and concern about medication waste.
The timing of doses and their impact on daily life was 
notable. The difficulty of the regimen has been shown to 
affect adherence in paediatrics improving once a routine is 
established [2]. In this current study participants had similar 
experiences but required support with the timing of admin-
istration, especially limiting this to waking hours. There are 
opportunities for this during the prescribing consultation, 
dispensing and medication review.
Challenges were identified with medication taken at 
school reflecting those previously described including access 
to medication and not wanting to take in front of peers [6, 
17, 18]. Despite there being national guidance on medica-
tion in schools in the UK [19] and USA [20] poor experi-
ences remain. A survey in Finland found inconsistencies in 
local school policies on medication [21]. This current study 
additionally identified difficulties around implementing 
dose changes. Information on changes to medication may be 
enhanced through the electronic transfer of clinic letters to 
GPs [22] and through direct electronic referral from hospital 
to community pharmacies [23]. Further work is required to 
support patients taking medication in school through better 
collaboration with healthcare professionals.
The most challenging aspect about having a child on med-
ication was remembering to administer. The consequences 
of poor adherence are well established [1, 2]. A number of 
strategies were employed to aid adherence including com-
pliance aids. The evidence base for medication compliance 
aids is limited and indicates a lack of patient benefit [24]. 
However, participants highlighted the additional benefit of 
compliance aids when transporting medication. This study 
highlights the importance of individualising patient care 
including considering the daily routine of each family.
Participants described receiving insufficient information 
in clinic verbally and through hand-written notes. The qual-
ity of instructions provided about medication influences 
adherence [1]. Healthcare practitioners may also influence 
adherence through patient engagement with conversations 
about medication [25]. Patients and parents require clear 
documentation of medication regimens.
Most participants looked up further information about 
their medication using the internet in accordance with pub-
lished studies [26, 27]. Consultations with healthcare pro-
fessionals are constrained by time [26]. A consequence of 
this is the desire to seek further information as explained by 
participants in this current study. However, poor interpreta-
tion of information about medications could lead to poor 
compliance [28]. A quality assessment tool may help chil-
dren and parents to assess online information [28]. There is 
an opportunity at the points of prescribing and dispensing to 
‘sign-post’ people to quality assured internet sites.
Some participants accessed on-line parent support groups 
which is observed in parents/patients with long-term condi-
tions [26–28]. Some found these groups informative whereas 
others found they raised more questions and disliked the 
‘expert parent’ approach. Further research has been sug-
gested around how pharmacists may support patients using 
the internet for medication information [28].
The absence of child friendly formulations was problem-
atic. To optimise the use of currently available formulations, 
training in swallowing medication could be provided by 
healthcare professionals which has previously proved suc-
cessful [29].
Participants expressed concern about wasted medication. 
In the UK approximately £300 million of NHS prescribed 
medication is wasted annually [30]. A recent study identi-
fied that more than 33% of medication returned to Dutch 
community pharmacies was preventable [31]. Globally, the 
total amount of medication consumed will increase by about 
3% through 2021 with spend approaching $1.5 trillion [32]. 
Therefore, initiatives that have been described to reduce 
waste [30] will be of increasing importance. This study 
confirms that medication waste is evident in paediatrics 
with parents expressing concern. There are opportunities 
for pharmacists to reduce waste through medication review.
Travelling with medication and taking medication outside 
of the home proved challenging. Parents were making deci-
sions around the stability of medication out of the fridge 
and usual packaging. This current study identified that more 
support and advice is required for parents/patients travelling 
with medication.
Challenges were described arranging supplies of medi-
cation in primary care as previously described [33]. These 
remain problematic for parents and patients who may not 
be informed of these potential problems. Contact between 
the hospital and the patient’s GP to agree the supply route 
should take place at the earliest opportunity. Better integra-
tion of pharmacists and GP working can optimise medica-
tion supply including synchronising repeat medications [34]. 
Timely transfer of information is recommended as a standard 
for good medicines optimisation [35].
Participants reported adverse effects from their medica-
tion. Treatment side effects have been shown to be a factor in 
non-adherence in paediatrics [2]. Parents and patients should 
be informed about potential adverse effects, their manage-
ment and how to seek advice. There remains further oppor-
tunity to understand how patients and parents would like to 
be informed about adverse effects.
The strength of this study is the detailed insight into how 
medication taking in children impacts on daily life from the 
perspective of the parent and/or the patient. The results from 
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the study can be incorporated in prescribing and dispensing 
consultations to further optimise medication use. These find-
ings may also be incorporated in a formal paediatric medica-
tion review with individual patients/parents.
Study limitations include the possibility of participants 
providing answers that they perceived to be acceptable. 
Consistency of the interview process was maintained with 
one researcher undertaking all interviews. The interviews 
took place whilst the patient was an in-patient which may 
have influenced how participants prioritised their experi-
ences. Undertaking the research at a single UK institu-
tion may limit the generalisability of the results. Whilst 
healthcare systems differ between countries, many of the 
experiences investigated are likely to be similar.
Conclusion
Parents and patients experience many challenges with their 
medication. This study has identified the following oppor-
tunities for healthcare professionals to contribute towards 
the optimal use of medication in paediatric patients:
• Engagement with patients and parents regarding medi-
cation choice/regimen to ensure treatment is achievable 
within their daily lives.
• Better collaboration with schools regarding patients’ 
medication especially when changes are made to treat-
ment.
• Provision of clear instructions regarding changes that 
patients/parents are expected to make to current treat-
ment.
• Sign-posting to quality assured internet sites about 
medication.
• Provide support to children to swallow solid dose forms.
• Ensure medication quantity is optimised to reduce waste.
• Early collaboration between hospital and primary care 
health providers to agree medication supply.
Minimally disruptive medication tailored to the realities 
patients’ daily lives could greatly improve quality of life 
[15]. This current study has identified how medication tak-
ing affects daily life when children and young people take 
regular medication.
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